Digest Network Come funziona
Network
/
Società
En
Non verificato

Enveda

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

7 comunicati stampa

Guarda tutti i comunicati
04/09/2025
Enveda Raises $150M Series D Funding to Reach Unicorn Status, Enrolls First Patient in Lead Program, and Adds Mikael Dolsten to Board of Directors
Fonte
Enveda
Emittente
Business Wire
1.00
0
28/05/2025
Tecnica
Biotecnologia
Salute
Sanità
Farmaceutica
Scienza
Tecnologie Varie
Software
Medicina - Varie
Industria
Enveda Reports Favorable Phase 1 Safety for Novel Oral Anti-Inflammatory, Launches Phase 1b Trial in Atopic Dermatitis
Fonte
Enveda
Emittente
Business Wire
1.00
0
26/02/2025
Scienza
Tecnica
Medicina - Varie
Biotecnologia
Farmaceutica
Salute
Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M
Fonte
Enveda
Emittente
Business Wire
1.00
0
05/02/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Tecnica
Medicina - Varie
Mercato del lavoro
Industria
Enveda Expands into Asthma with First-in-Class Lead Asset ENV-294 and Assembles World-Class Advisory Board
Fonte
Enveda
Emittente
Business Wire
1.00
0
10/01/2025
Enveda Welcomes Jason Kim as Chief Financial Officer
Fonte
Enveda
Emittente
Business Wire
1.00
0
21/11/2024
Information Technology
Salute
Tecnica
Software
Biotecnologia
Industria
Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates
Fonte
Enveda
Emittente
Business Wire
1.00
0
13/11/2024
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Enveda Announces First Candidate Discovered From Nature Using AI Advances to Clinical Trials
Fonte
Enveda
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0